1.
Clin Transplant
; 37(8): e15045, 2023 08.
Artículo
en Inglés
| MEDLINE
| ID: mdl-37306944
RESUMEN
The advent of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in China at the end of 2019 has developed into a global outbreak, and COVID- 19 is an ongoing major public health issue. During the pandemic, transplant programs had to devise strategies to deal with the possibility of COVID-19-positive donors and recipients. We describe the case of a heart transplant recipient who tested positive with the SARS- CoV2 swab upon admission to our Unit of Cardiac Surgery when a suitable donor became available. Given his clinical status of end-stage heart failure and the absence of imaging and clinical signs suggestive of COVID-19, and his having been vaccinated with three doses, we decided to proceed with the transplant.
Asunto(s)
COVID-19 , Trasplante de Corazón , Humanos , SARS-CoV-2 , Donantes de Tejidos , China , Receptores de Trasplantes
2.
J Cardiovasc Med (Hagerstown)
; 25(3): 243-245, 2024 Mar 01.
Artículo
en Inglés
| MEDLINE
| ID: mdl-38305142
Asunto(s)
Trasplante de Corazón , Corazón , Humanos , Donantes de Tejidos , Tórax , Trasplante de Corazón/efectos adversos
3.
Braz J Cardiovasc Surg
; 38(2): 309-311, 2023 04 23.
Artículo
en Inglés
| MEDLINE
| ID: mdl-36459473
4.
5.
Rev. bras. cir. cardiovasc
; Rev. bras. cir. cardiovasc;38(2): 309-311, 2023. tab, graf
Artículo
en Inglés
|
LILACS-Express
| LILACS
| ID: biblio-1431514